SAFC-Jerusalem Prays $30 Million CMO Expansion Investment Pays Off in Attracting More High-Potency APIs Clients
SAFC-Jerusalem Prays $30 Million CMO Expansion Investment Pays Off in Attracting More High-Potency APIs Clients
SUGAR LAND--October 12, 2010--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Mention the ancient city of Jerusalem, Israel, and the religious overtones of the city tend to come to mind. While fully acknowledging the sanctity of its historical significance, it would be remiss to ignore the fact that the city has a place in the high-tech secular world of the 21st century Pharmaceutical Industry. Case in point--SAFC-Jerusalem (Jerusalem), a division of Sigma-Aldrich Corporation (NASDAQ:SIAL) (St. Louis, Missouri) has just completed a $30 million investment to expand its contract manufacturing (CMO) facility in Jerusalem (source: Industrial Info's Pharmaceutical Tracker - Online Database).
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- U.S. Supplement Production Brings Millions in Spending
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips